Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardiff Oncology (CRDF) Debt to Equity (2016 - 2020)

Historic Debt to Equity for Cardiff Oncology (CRDF) over the last 7 years, with Q2 2020 value amounting to $0.01.

  • Cardiff Oncology's Debt to Equity changed N/A to $0.01 in Q2 2020 from the same period last year, while for Jun 2020 it was $0.01, marking a year-over-year change of. This contributed to the annual value of $0.2 for FY2017, which is 7553.48% down from last year.
  • Per Cardiff Oncology's latest filing, its Debt to Equity stood at $0.01 for Q2 2020.
  • In the past 5 years, Cardiff Oncology's Debt to Equity ranged from a high of $1.55 in Q1 2017 and a low of $0.01 during Q2 2020
  • For the 4-year period, Cardiff Oncology's Debt to Equity averaged around $0.52, with its median value being $0.43 (2016).
  • Per our database at Business Quant, Cardiff Oncology's Debt to Equity soared by 29368.56% in 2017 and then tumbled by 8381.7% in 2018.
  • Cardiff Oncology's Debt to Equity (Quarter) stood at $0.84 in 2016, then tumbled by 75.53% to $0.2 in 2017, then grew by 22.7% to $0.25 in 2018, then tumbled by 96.17% to $0.01 in 2020.
  • Its Debt to Equity was $0.01 in Q2 2020, compared to $0.25 in Q1 2018 and $0.2 in Q4 2017.